secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2024-04-03T23:59:59+00:00
Accession:  0001628280-24-014573
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncology Institute issues FY2023 results slide presentation; no specific figures in filing excerpt
--------------------------------------------------------------------------------

- Presentation covers financial results for Q4 and full year ended Dec 31, 2023.
- Company also provided business updates and guidance for the year ending Dec 31, 2023.
- No quantitative data (revenue, EPS, etc.) appears in the provided excerpt of Exhibit 99.1.
- Investors should review the full slide deck for actual performance metrics.
- Filing date April 3, 2024; tickers TOI and TOIIW.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000162828024014573/0001628280-24-014573-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000162828024014573/toi-20240403.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-014573

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer